Skip to content
10-Q

Quarterly Report

AN2 Therapeutics, Inc. ANTX

0001193125-25-277673

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 27.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 30.28M sh
Shares Diluted Q3 2025 · Sep 30, 2025 30.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.84M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.81M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$24.6M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$43.98M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $18M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $21.35M
Stockholders Equity Q3 2025 · Sep 30, 2025 $60.38M
Stockholders Equity Q3 2025 · Jun 30, 2025 $68.84M
Stockholders Equity Q3 2025 · Mar 31, 2025 $73.33M
Stockholders Equity Q3 2025 · Dec 31, 2024 $81.85M
Stockholders Equity Q3 2025 · Sep 30, 2024 $87.67M
Stockholders Equity Q3 2025 · Jun 30, 2024 $98.35M
Stockholders Equity Q3 2025 · Mar 31, 2024 $110.6M
Stockholders Equity Q3 2025 · Dec 31, 2023 $124.7M
Total Liabilities Q3 2025 · Sep 30, 2025 $6.86M
Total Liabilities Q3 2025 · Dec 31, 2024 $10.24M
Current Assets Q3 2025 · Sep 30, 2025 $64.02M
Current Assets Q3 2025 · Dec 31, 2024 $86.26M
Total Assets Q3 2025 · Sep 30, 2025 $67.24M
Total Assets Q3 2025 · Dec 31, 2024 $92.09M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.88
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.43
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.47
Eps Basic Q3 2025 · Sep 30, 2025 −$0.31
Eps Basic Q3 2025 · Sep 30, 2025 −$0.88
Eps Basic Q3 2025 · Sep 30, 2024 −$0.43
Eps Basic Q3 2025 · Sep 30, 2024 −$1.47
Sga Expense Q3 2025 · Sep 30, 2025 $3.04M
Sga Expense Q3 2025 · Sep 30, 2025 $10.9M
Sga Expense Q3 2025 · Sep 30, 2024 $3.48M
Sga Expense Q3 2025 · Sep 30, 2024 $10.86M
Rd Expense Q3 2025 · Sep 30, 2025 $7M
Rd Expense Q3 2025 · Sep 30, 2025 $17.89M
Rd Expense Q3 2025 · Sep 30, 2024 $8.29M
Rd Expense Q3 2025 · Sep 30, 2024 $35.09M
Net Income Q3 2025 · Sep 30, 2025 −$9.35M
Net Income Q3 2025 · Sep 30, 2025 −$26.5M
Net Income Q3 2025 · Jun 30, 2025 −$6.46M
Net Income Q3 2025 · Mar 31, 2025 −$10.65M
Net Income Q3 2025 · Sep 30, 2024 −$12.75M
Net Income Q3 2025 · Sep 30, 2024 −$43.8M
Net Income Q3 2025 · Jun 30, 2024 −$14.44M
Net Income Q3 2025 · Mar 31, 2024 −$16.62M
Operating Income Q3 2025 · Sep 30, 2025 −$10.04M
Operating Income Q3 2025 · Sep 30, 2025 −$28.79M
Operating Income Q3 2025 · Sep 30, 2024 −$14.01M
Operating Income Q3 2025 · Sep 30, 2024 −$48.19M